Ausgabe 3/2010
Inhalt (31 Artikel)
Increased expression of enolase α in human breast cancer confers tamoxifen resistance in human breast cancer cells
Shih-Hsin Tu, Chih-Chiang Chang, Ching-Shyang Chen, Ka-Wai Tam, Ying-Jan Wang, Chia-Hwa Lee, Hsiao-Wei Lin, Tzu-Chun Cheng, Ching-Shui Huang, Jan-Show Chu, Neng-Yao Shih, Li-Ching Chen, Sy-Jye Leu, Yuan-Soon Ho, Chih-Hsiung Wu
Loss of CSMD1 expression is associated with high tumour grade and poor survival in invasive ductal breast carcinoma
Mohamed Kamal, Abeer M. Shaaban, Liqun Zhang, Clare Walker, Sally Gray, Nalin Thakker, Carmel Toomes, Valerie Speirs, Sandra M. Bell
A prospective study of variability in mammographic density during the menstrual cycle
Monica Morrow, Robert T. Chatterton Jr., Alfred W. Rademaker, Nanjiang Hou, V. Craig Jordan, R. Edward Hendrick, Seema A. Khan
An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers
Rachael Natrajan, Britta Weigelt, Alan Mackay, Felipe C. Geyer, Anita Grigoriadis, David S. P. Tan, Chris Jones, Christopher J. Lord, Radost Vatcheva, Socorro M. Rodriguez-Pinilla, Jose Palacios, Alan Ashworth, Jorge S. Reis-Filho
Targeting glucosylceramide synthase downregulates expression of the multidrug resistance gene MDR1 and sensitizes breast carcinoma cells to anticancer drugs
Yanlin Sun, Tingguo Zhang, Peng Gao, Bin Meng, Yongsheng Gao, Xiao Wang, Jianping Zhang, Hao Wang, Xiaojuan Wu, Wenxin Zheng, Gengyin Zhou
Breast cancer cells can switch between estrogen receptor α and ErbB signaling and combined treatment against both signaling pathways postpones development of resistance
Katrine Sonne-Hansen, Ida C. Norrie, Kristina B. Emdal, Rikke V. Benjaminsen, Thomas Frogne, Ib J. Christiansen, Tove Kirkegaard, Anne E. Lykkesfeldt
High levels of uPA and PAI-1 predict a good response to anthracyclines
Simona Borstnar, Aleksander Sadikov, Barbara Mozina, Tanja Cufer
High levels of uPA and PAI-1 predict a good response to anthracyclines
Kathleen I. Pritchard
Immediate post-mastectomy breast reconstruction followed by radiotherapy: risk factors for complications
Didier Cowen, E. Gross, P. Rouannet, E. Teissier, S. Ellis, M. Resbeut, A. Tallet, V. Vaini Cowen, D. Azria, J. M. Hannoun-Levi
Discussion: immediate post-mastectomy breast reconstruction followed by radiotherapy: risk factors for complications
Amy K. Alderman, Reshma Jagsi
The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks: results from a multicenter study among 15,542 BRCA1 and BRCA2 mutation carriers
Anna Jakubowska, Dominik Rozkrut, Antonis Antoniou, Ute Hamann, Jan Lubinski
Metabolic profile, physical activity, and mortality in breast cancer patients
Aina Emaus, Marit Bragelien Veierød, Steinar Tretli, Sissi Espetvedt Finstad, Randi Selmer, Anne-Sofie Furberg, Leslie Bernstein, Ellen Schlichting, Inger Thune
Serum insulin-like growth factor (IGF)-1 and IGF binding protein-3 in relation to breast cancer among Hispanic and white, non-Hispanic women in the US Southwest
Dana E. Rollison, Anna R. Giuliano, Betsy C. Risendal, Carol Sweeney, David Boulware, Christine Laronga, Kathy B. Baumgartner, Tim Byers, Martha L. Slattery
Evaluation of breast cancer service screening programme with a Bayesian approach: mortality analysis in a Finnish region
Jenny Chia-Yun Wu, Ahti Anttila, Amy Ming-Fang Yen, Matti Hakama, Irma Saarenmaa, Tytti Sarkeala, Nea Malila, Anssi Auvinen, Sherry Yueh-Hsia Chiu, Tony Hsiu-Hsi Chen
Reductions in use of hormone replacement therapy: effects on Swedish breast cancer incidence trends only seen after several years
Mats Lambe, Annette Wigertz, Marit Holmqvist, Jan Adolfsson, Carola Bardage, Tommy Fornander, Per Karlsson, Viveca Odlind, Ingemar Persson, Johan Ahlgren, Leif Bergkvist
Gene promoter methylation is associated with increased mortality among women with breast cancer
Xinran Xu, Marilie D. Gammon, Yujing Zhang, Yoon Hee Cho, James G. Wetmur, Patrick T. Bradshaw, Gail Garbowski, Hanina Hibshoosh, Susan L. Teitelbaum, Alfred I. Neugut, Regina M. Santella, Jia Chen
A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk
Rongxi Yang, Bettina Schlehe, Kari Hemminki, Christian Sutter, Peter Bugert, Barbara Wappenschmidt, Juliane Volkmann, Raymonda Varon, Bernhard H. F. Weber, Dieter Niederacher, Norbert Arnold, Alfons Meindl, Claus R. Bartram, Rita K. Schmutzler, Barbara Burwinkel
Glutathione S-transferase M1 polymorphism and breast cancer susceptibility: a meta-analysis involving 46,281 subjects
Li-Xin Qiu, Hui Yuan, Ke-Da Yu, Chen Mao, Bo Chen, Ping Zhan, Kai Xue, Jian Zhang, Xi-Chun Hu
Impact of multiple caregiving roles on elevated depressed mood in early-stage breast cancer patients and same-age controls
Ellen H. Bailey, Maria Pérez, Rebecca L. Aft, Ying Liu, Mario Schootman, Donna B. Jeffe
Lack of association between catechol-O-methyltransferase Val108/158Met polymorphism and breast cancer risk: a meta-analysis of 25,627 cases and 34,222 controls
Chen Mao, Xi-Wen Wang, Li-Xin Qiu, Ru-Yan Liao, Hong Ding, Qing Chen
Expression of TGF-β signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics
Jonine D. Figueroa, Kathleen C. Flanders, Montserrat Garcia-Closas, William F. Anderson, Xiaohong R. Yang, Rayna K. Matsuno, Máire A. Duggan, Ruth M. Pfeiffer, Akira Ooshima, Robert Cornelison, Gretchen L. Gierach, Louise A. Brinton, Jolanta Lissowska, Beata Peplonska, Lalage M. Wakefield, Mark E. Sherman
Combined genetic effect of CDK7 and ESR1 polymorphisms on breast cancer
Sujee Jeon, Ji-Yeob Choi, Kyoung-Mu Lee, Sue K. Park, Keun-Young Yoo, Dong-Young Noh, Sei-Hyun Ahn, Daehee Kang
Influence of birthplace on breast cancer diagnosis and treatment for Hispanic women
Elena M. Kouri, Yulei He, Eric P. Winer, Nancy L. Keating
Density of tumour stroma is correlated to outcome after adoptive transfer of CD4+ and CD8+ T cells in a murine mammary carcinoma model
Michele L. Martin, Erika M. Wall, Emily Sandwith, Adam Girardin, Katy Milne, Peter H. Watson, Brad H. Nelson
Two-stage case–control study of DNMT-1 and DNMT-3B gene variants and breast cancer risk
Chuanzhong Ye, Alicia Beeghly-Fadiel, Wei Lu, Jirong Long, Xiao Ou Shu, Yu-Tang Gao, Wei Zheng, Qiuyin Cai
Reliable data on 5- and 10-year survival provide accurate estimates of 15-year survival in estrogen receptor-positive early-stage breast cancer
Christina I. Herold, Benjamin Djulbegovic, Iztok Hozo, Gary H. Lyman
Overexpression of p53 is correlated with poor outcome in premenopausal women with breast cancer treated with tamoxifen after chemotherapy
Hee Sung Kim, Cha Kyong Yom, Hee Jeong Kim, Jong Won Lee, Jin Hee Sohn, Jun Ho Kim, Yong Lai Park, Sei Hyun Ahn
Severe prolonged cholestatic hepatitis caused by exemestane
Ting Bao, John Fetting, Laura Mumford, Jane Zorzi, Karineh Shahverdi, Stacie Jeter, Frank Herlong, Vered Stearns, Linda Lee
Tamoxifen sensitivity and estrogen receptor mRNA levels
P. N. Span, H. W. van Laarhoven, F. C. G. J. Sweep
Correlation between consanguineous marriages and age-standardized mortality rate due to breast cancer, an ecologic study
Mostafa Saadat, Iraj Saadat
Sustained lower rates of breast cancer incidence in France in 2007
Brigitte Séradour, Hubert Allemand, Alain Weill, Philippe Ricordeau